You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Cost-utility and budget impact analysis of CPAP therapy compared to no treatment in the management of moderate to severe obstructive sleep apnea in Colombia from a third-party payer perspective
|
---|---|
Published in |
Expert Review of Pharmacoeconomics and Outcomes Research, March 2023
|
DOI | 10.1080/14737167.2023.2181792 |
Pubmed ID | |
Authors |
Antonio Robles, Yaneth Gil-Rojas, Devi Amaya, Fabián Hernández, Franklin Escobar-Cordoba, Marco Venegas, Steve Amado, Sonia Restrepo-Gualteros, Jorge Echeverry, Fernando Marín, Sandra Zabala, María Angélica Bazurto-Zapata, Melike Deger |
X Demographics
The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Colombia | 4 | 80% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 14 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 5 | 36% |
Student > Bachelor | 1 | 7% |
Other | 1 | 7% |
Researcher | 1 | 7% |
Student > Postgraduate | 1 | 7% |
Other | 0 | 0% |
Unknown | 5 | 36% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 2 | 14% |
Nursing and Health Professions | 2 | 14% |
Engineering | 2 | 14% |
Chemistry | 1 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 7% |
Other | 0 | 0% |
Unknown | 6 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 March 2023.
All research outputs
#8,235,892
of 25,498,750 outputs
Outputs from Expert Review of Pharmacoeconomics and Outcomes Research
#244
of 766 outputs
Outputs of similar age
#143,781
of 424,526 outputs
Outputs of similar age from Expert Review of Pharmacoeconomics and Outcomes Research
#3
of 11 outputs
Altmetric has tracked 25,498,750 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 766 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.